United States: Building A Health App? Part 3: What You Need To Know About FDA's Regulation Of Mobile Apps

This is our third installment in our series about the legal issues involved in launching a health app, which the U.S. Food and Drug Administration ("FDA") refers to as "mobile apps." The goal of this post is to provide you with a basic understanding of FDA's evolving approach to mobile apps so that you can make informed decisions about the legal consequences of your app's functionality.

Back to Basics

Anyone involved in the development of a mobile health app should keep handy the FDA definition of a "medical device," which Section 201(h) of the Federal Food, Drug, and Cosmetic Act, defines as:

"... an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part, or accessory, which is ...intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals..."

There is no exception in this definition for mobile apps, and as we will see below, FDA believes it is within its authority to regulate mobile apps as medical devices. We can therefore extract from the definition of medical device a general principle that developers should keep in mind:

If a mobile app is intended for use in performing a medical device function (i.e., for diagnosis of disease or other conditions, or the cure, mitigation, treatment or prevention of disease) it is a medical device and therefore subject to FDA oversight."

This is true regardless of the platform. Health apps running on iOS, Android, or any other platform can trigger FDA oversight. The reality is that thousands of mobile apps made available on the various app stores are, in fact, mobile medical apps that are turning their users' phones into medical devices that must comply with FDA regulations.

Risk-Based Regulatory Classification

Medical devices, including mobile apps, are classified into the following three categories based on their risk profile:

  • Class I (general controls; lowest risk);
  • Class II (special & general controls); and
  • Class III (premarket approval; highest risk).

The classifications and controls necessary for many Class I, II, and III devices are described in regulations that are specific to each device type. In the context of mobile apps, if the intended use or function of the app falls within the scope of an already defined device regulation, the app will be classified as a medical device. As a result of such classification, the app must meet all of the controls and application requirements for that device type. Take for example an app developer that claims its app can score a user's cognitive function based on a battery of cognitive tasks. This type of app will fall within the existing class of "computerized cognitive assessment aids," which are regulated as Class II devices. (For those interested, see 21 C.F.R. § 882.1470). This classification requires a 510(k) application to be submitted to FDA prior to commercialization.

You might be wondering what happens to mobile apps that don't fit into an existing regulation. Fortunately, FDA has issued final Guidance for Mobile Medical Applications ("Guidance") that helps answer this and other questions.

The Guidance: Our Lodestar for Understanding Mobile App Regulation

At this point, the Guidance represents the primary tool that developers can use to determine the extent to which FDA will regulate their app. The Guidance defines a "mobile medical application" to mean a mobile app that meets the definition of device (see discussion in the Back to Basics section, above) and either is intended to be used as an accessory to a regulated medical device, or is intended to transform a mobile platform into a regulated medical device.

Mobile apps that control the inflation or deflation of a blood pressure cuff or control the delivery of insulin on an insulin pump are two examples of apps that are accessories to regulated medical devices. The other category of mobile medical apps—those apps that transform mobile platforms into medical devices—is best exemplified by apps that use the platform's built-in sensors or other technology for medical device functions, such as attachment of a blood glucose strip reader to a smartphone.

As stated in its Guidance, FDA intends to only apply their oversight to those mobile medical apps with functionality that could pose a risk to a patient's safety if the app were to not function as intended. To assist developers, the Guidance distinguishes between apps that will be subject to the normal regulatory oversight and those apps where the FDA believes it is appropriate to exercise enforcement discretion given the low risk of patient safety

Mobile Medical Apps That Are Subject to Traditional Regulatory Oversight

FDA's Guidance provides examples of mobile medical apps that will not receive enforcement discretion and will therefore be subject to the FDA's traditional regulatory paradigm. One category of apps is particularly applicable to many of the health apps currently being developed. This category includes apps that perform "patient-specific analysis and provide patient-specific diagnosis, or treatment recommendations." The Guidance provides examples, including apps that use patient-specific parameters to create a dosage plan for radiation therapy, and Computer-Aided Detection (CAD) software that assists providers in detecting abnormal tissue, such as cancerous breast tissue. These types of high risk mobile apps will be subject to the traditional regulatory pathway for approval for devices, which will require the developer to:

  1. Register with FDA as a medical device manufacturer;
  2. Submit a 510(k) for Class II devices or a PMA for Class III devices;
  3. Establish a quality management system compliant with good manufacturing practices; and
  4. Make itself available for FDA inspection.

Quality management systems must include processes for complaint handling, corrective actions, documentation control and other compliance-related activities. Developing a quality system that complies with FDA regulations requires experienced personnel or regulatory consultants and takes constant resources and effort to maintain compliance.

Mobile Medical Apps That Are Subject to Enforcement Discretion

The FDA's Guidance provides a number of categories of mobile apps for which the FDA intends to exercise enforcement discretion. These include mobile apps that:

  • Help patients (i.e., users) self-manage their disease or conditions without providing specific treatment or treatment suggestions;
  • Provide patients with simple tools to organize and track their health information;
  • Provide easy access to information related to patients' health conditions or treatments;
  • Help patients document, show, or communicate potential medical conditions to health care providers;
  • Automate simple tasks for health care providers;
  • Enable patients or providers to interact with Personal Health Record (PHR) or Electronic Health Record (EHR) systems; or
  • Intended to transfer, store, convert format, and display medical device data in its original format from a medical device.

Some mobile apps in the above categories may be considered mobile medical apps, and others might not. For those mobile apps that are devices, FDA intends to exercise enforcement discretion because they pose a low risk to patients.

21st Century Cures Act

As a result of the 21st Century Cures Act (the "Act"), the definition of "device" will exclude software that:

  • Provides administrative support of health care facility (inc. lab workflow, appointment schedulers).
  • Maintains or encourage a healthy lifestyle, unrelated to diagnosis, cure, mitigation, prevention, or treatment of disease or condition.
  • Relate to electronic patient records that transfer, store, convert formats, or display patient information (do not "interpret or analyze") and that are created, stored, transferred, reviewed by professional or staff.
  • Transfers, stores, converts formats or display lab test or device data.
  • Meets all of the following: (i) displays, analyzes or prints medical information about a patient or other medical information (such as practice guidelines); (ii) supports or provides recommendations to a healthcare professional (i.e., clinical decision support) about prevention, diagnosis or treatment of a disease or condition; and (iii) enables the health professional to independently review the basis for such recommendations rather than primarily rely on it when making diagnostic and treatment decisions.

In general, the first four software categories exempted under the Act align with FDA's approach in its Guidance of exercising enforcement discretion for apps that do not directly relate to the diagnosis or cure of specific diseases or conditions. The fifth category will become increasingly important to developers that provide clinical decision support ("CDS") to healthcare professionals. Many companies have been waiting for FDA to issue CDS software guidance since 2015, but FDA did not release such guidance before the Act limited FDA's ability to regulate CDS software. However, FDA may still regulate and issue guidance for any CDS software that does not meet all of the criteria described in the fifth category above.

FDA amended its Guidance to note this revised definition and to announce its plans to revise the Guidance to "represent [their] current thinking on the topic." Unfortunately, the agency has yet to produce such regulations.


It is important to keep in mind that health apps intended for a medical or wellness purpose, as well as the companies that develop such apps, are fully subject to FDA medical device regulations unless the app's functionality falls under the enforcement discretion of the Guidance or has been exempted from regulation by the 21st Century Cures Act. Apps that satisfy the definition of a medical device yet fail to meet either one of these regulatory "off ramps" will be subject to the same types of FDA regulations that traditional manufacturers face. These obligations are time-consuming and expensive, even for a well-financed start up. It is therefore important for developers to analyze each function of their app to determine whether it causes the app to move out of FDA's enforcement discretion and into the traditional regulatory framework. Those in this space should be on the lookout for new FDA rulemaking on these issues.

Stay tuned next week for our next post in this series which will explore regulation of health apps by the Federal Trade Commission (FTC).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Wilson Elser Moskowitz Edelman & Dicker LLP
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Wilson Elser Moskowitz Edelman & Dicker LLP
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions